What is LOPJLB’s current signal on ALGS?

LOPJLB’s latest quantitative signal on Aligos Therapeutics, Inc. (ALGS) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is ALGS in?

Aligos Therapeutics, Inc. (ALGS) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Where is Aligos Therapeutics, Inc. based / listed?

Aligos Therapeutics, Inc. is based in US, listed on NASDAQ.

Aligos Therapeutics, Inc. (ALGS)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$5.34+0.56%Close

SELLRECOVERY · day 10

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $33M
Beta: 2.36
P/E (TTM): -0.74

Short % float: 14.78%
Days to cover: 14.3
SI change: +1.6%

1W: -3.61%
1M: +0.19%

vs SPY 1W: -4.77%
vs SPY 1M: -2.80%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for significant unmet medical needs in both viral and liver diseases. Key candidates in its pipeline include ALG-010133, an s-antigen transport-inhibiting…

Employees: 82
Headquarters: US
Founded: 2020
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 6.2M
Float: 77.5%

aligos.com ↗

Key executives

Lawrence Blatt — Chief Executive Officer, President & Chairman of the Board

Lesley Ann Calhoun — Executive Vice President, Chief Financial Officer & Chief Operating Officer

Julian A. Symons DPHIL — Executive Vice President & Chief Scientific Officer

SEC filings

EDGAR · CIK 17994480 · ALGS

Analyst consensus

Buy

Bullish360.0%

Neutral240.0%

Bearish00.0%

L $20.00Avg $20.00H $20.00

Target$20.00+274.53%

Last$5.34

Key stats

Prediction markets

Company news